Century Therapeutics, Inc. (IPSC)
Market Closed
30 Jul, 20:00
NASDAQ (NGS) NASDAQ (NGS) Primary $
2. 19
+0.17
+8.4158%
$
189.59M Market Cap
- P/E Ratio
- Div Yield
571,372 Volume
-2.04 Eps
$ 2.02
Previous Close 
Want to track IPSC and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Century Therapeutics, Inc. (IPSC) Statistics
Valuation metrics
Market Cap 189.59M
Enterprise value 179.64M
Trailing P/E (ttm) -1.69
Forward P/E -
PEG ratio 0
Price/Sales (ttm) -
Price/Book (mrq) 0.69
Enterprise Value/Revenue -
Enterprise Value/EBITDA -2
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 594.74K
Average volume (90 days) 1.39M
Price summary
52-Week low 0.43
52-Week high 3.04
Beta -
50-Day moving average 2.28
200-Day moving average 2.2
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -0.33%
Return on equity -0.53%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -1.25
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 1.56
Total debt (mrq) -
Total Debt/Equity (mrq) 0.18
Current ratio (mrq) 10.25%
Book value per share (mrq) 3.06
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
